Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    15122205 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: RAD001 (everolimus)
2 Terminated
Has Results
Trial of RAD001 in Triple Negative Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: RAD 001

Indicates status has not been verified in more than two years